Whistleblower accuses FDA of ‘relaxing review standards’…

US – Federal: The US Office of Special Counsel (OSC) has written to the president and Congress advising them that the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) had “relaxed its standards of review for certain tobacco products”. A CTP toxicologist-turned-whistleblower disclosed that a 2019 memo to CTP scientists on how to evaluate potentially harmful ingredients in substantial equivalence applications directed » Continue Reading. ...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ Whistleblower accuses FDA of ‘relaxing review standards’… ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Whistleblower accuses FDA of ‘relaxing review standards’… ”






      US – Federal: The US Office of Special Counsel (OSC) has written to the president and Congress advising them that the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) had “relaxed its standards of review for certain tobacco products”. A CTP toxicologist-turned-whistleblower disclosed that a 2019 memo to CTP scientists on how to evaluate potentially harmful ingredients in substantial equivalence applications directed » Continue Reading. ...

      Restricted content. Do you want to read more?